T

Talkmed Group Ltd
SGX:5G3

Watchlist Manager
Talkmed Group Ltd
SGX:5G3
Watchlist
Price: 0.44 SGD -2.22%
Market Cap: 584.2m SGD
Have any thoughts about
Talkmed Group Ltd?
Write Note

Wall Street
Price Targets

5G3 Price Targets Summary
Talkmed Group Ltd

There are no price targets for 5G3.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Talkmed Group Ltd Competitors:
Price Targets
AND
Andlauer Healthcare Group Inc
11% Upside
LH
Laboratory Corporation of America Holdings
6% Upside
OPTIMAX
Optimax Holdings Bhd
31% Upside
LALPATHLAB
Dr. Lal PathLabs Ltd
8% Upside
DGX
Quest Diagnostics Inc
1% Upside
THYROCARE
Thyrocare Technologies Ltd
5% Downside
VIJAYA
Vijaya Diagnostic Centre Ltd
10% Downside
VOX
Voxel SA
22% Downside

Revenue
Forecast

Revenue Estimate
Talkmed Group Ltd

For the last 8 years the compound annual growth rate for Talkmed Group Ltd's revenue is 3%. The projected CAGR for the next 3 years is -12%.

3%
Past Growth
-12%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Talkmed Group Ltd

For the last 8 years the compound annual growth rate for Talkmed Group Ltd's operating income is -3%. The projected CAGR for the next 3 years is -15%.

-3%
Past Growth
-15%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Talkmed Group Ltd

For the last 8 years the compound annual growth rate for Talkmed Group Ltd's net income is -2%. The projected CAGR for the next 3 years is -6%.

-2%
Past Growth
-6%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 5G3's stock price target?
Not Available

5G3 doesn't have any price targets made by Wall Street professionals.

What is Talkmed Group Ltd's Revenue forecast?
Projected CAGR
-12%

For the last 8 years the compound annual growth rate for Talkmed Group Ltd's revenue is 3%. The projected CAGR for the next 3 years is -12%.

What is Talkmed Group Ltd's Operating Income forecast?
Projected CAGR
-15%

For the last 8 years the compound annual growth rate for Talkmed Group Ltd's operating income is -3%. The projected CAGR for the next 3 years is -15%.

What is Talkmed Group Ltd's Net Income forecast?
Projected CAGR
-6%

For the last 8 years the compound annual growth rate for Talkmed Group Ltd's net income is -2%. The projected CAGR for the next 3 years is -6%.

Back to Top